Cancer Research and Treatment

REVIEW ARTICLE 2023 October 5 Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer
Hormone receptor–positive (HR+) disease is the most frequently diagnosed subtype of breast cancer. Among tumor subtypes, natural course of HR+ breast cancer is indolent with favorable prognosis compared to other subtypes such as human epidermal growth factor protein 2–positiv...

ORIGINAL ARTICLE 2023 June 12 Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients
Purpose Patient-derived tumor cells can be a powerful resource for studying pathophysiological mechanisms and developing robust strategies for precision medicine. However, establishing organoids from patient-derived cells is challenging because of limited access to tissue specim...

ORIGINAL ARTICLE 2023 June 15 Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients
Purpose Neuregulin 1 (NRG1) gene fusion is a potentially actionable oncogenic driver. The oncoprotein binds to ERBB3-ERBB2 heterodimers and activates downstream signaling, supporting a therapeutic approach for inhibiting ERBB3/ERBB2. However, the frequency and clinicopathologica...

ORIGINAL ARTICLE 2023 April 7 A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
Purpose Several previous studies and case reports have reported ethanol-induced symptoms in patients receiving anticancer drugs containing ethanol. Most docetaxel formulations contain ethanol as a solvent. However, there are insufficient data on ethanol-induced symptoms when doc...

Current Issue

Volume 55(4); Oct 2023

Volume 55(3); July 2023

Volume 55(2); April 2023

Most-read are based on citations from 2021 ~ 2023.

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018 ( 16067 times )

Seri Hong, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries

Cancer Res Treat. 2021;53(2):301-315. Published online March 17, 2021 DOI: https://doi.org/10.4143/crt.2021.291

Cited By 207

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019 ( 15722 times )

Mee Joo Kang, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries

Cancer Res Treat. 2022;54(2):330-344. Published online March 16, 2022 DOI: https://doi.org/10.4143/crt.2022.128

Cited By 129

Pediatric cancer

Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAF^V600E-Mutated Langerhans Cell Histiocytosis ( 14788 times )

Ying Yang, Dong Wang, Lei Cui, Hong-Hao Ma, Li Zhang, Hong-Yun Lian, Qing Zhang, Xiao-Xi Zhao, Li-Ping Zhang, Yun-Ze Zhao, Na Li, Tian-You Wang, Zhi-Gang Li, Rui Zhang

Cancer Res Treat. 2021;53(1):261-269. Published online September 15, 2020 DOI: https://doi.org/10.4143/crt.2020.769

Cited By 12

Prediction of Cancer Incidence and Mortality in Korea, 2021 ( 10866 times )

Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo

Cancer Res Treat. 2021;53(2):316-322. Published online March 17, 2021 DOI: https://doi.org/10.4143/crt.2021.290

Cited By 58

Prediction of Cancer Incidence and Mortality in Korea, 2022 ( 9936 times )

Kyu-Won Jung, Young-Joo Won, Mee Joo Kang, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo

Cancer Res Treat. 2022;54(2):345-351. Published online March 21, 2022 DOI: https://doi.org/10.4143/crt.2022.179

Cited By 28

Immunotherapy

The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients ( 9304 times )

Si-Qi Tang, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Lei Chen, Yuan Zhang, Ying Guo, Qing Liu, Ying Sun, Cheng Xu, Jun Ma

Cancer Res Treat. 2021;53(2):339-354. Published online November 6, 2020 DOI: https://doi.org/10.4143/crt.2020.790

Cited By 51

Head and Neck Cancer

Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma ( 9304 times )

Wan-Ru Zhang, Yu-Yun Du, Chun-Yan Guo, Han-Xing Zhou, Jie-Yi Lin, Xiao-Han Meng, Hao-Yuan Mo, Dong-Hua Luo

Cancer Res Treat. 2021;53(4):991-1003. Published online January 13, 2021 DOI: https://doi.org/10.4143/crt.2020.1298

Basic

TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis ( 9183 times )

Kyungsoo Jung, Joon-Seok Choi, Beom-Mo Koo, Yu Jin Kim, Ji-Young Song, Minjung Sung, Eun Sol Chang, Ka-Won Noh, Sungbin An, Mi-Sook Lee, Kyoung Song, Hannah Lee, Ryong Nam Kim, Young Kee Shin, Doo-Yi Oh, Yoon-La Choi

Cancer Res Treat. 2021;53(1):9-24. Published online September 16, 2020 DOI: https://doi.org/10.4143/crt.2020.434

Cited By 8

Breast Cancer

Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer ( 8415 times )

Erwin Danil Yulian, Nurjati Chairani Siregar, Bajuadji

Cancer Res Treat. 2021;53(4):1072-1083. Published online March 9, 2021 DOI: https://doi.org/10.4143/crt.2020.1024

Cited By 14

Practical Advice for South Korean Medical Researchers Regarding Open-Access and Predatory Journals ( 8309 times )

Chai Hong Rim

Cancer Res Treat. 2021;53(1):1-8. Published online September 21, 2020 DOI: https://doi.org/10.4143/crt.2020.816

Cited By 1